Full Text
Cost Effectiveness of Sorafenib Versus SBRT for Advanced Hepatocellular Carcinoma

Abstract

Authors

A Chan H Leung

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×